Page 151 - IJB-10-5

International Journal of Bioprinting Liver printing: from structure to application

Acknowledgments 4. Macchi F, Sadler KC. Unraveling the epigenetic basis of
liver development, regeneration and disease. Trends Genet.
None. 2020;36(8):587-597.
doi: 10.1016/j.tig.2020.05.002
Funding
5. Matchett KP, Wilson-Kanamori JR, Portman JR, et al.
This research was supported by the National Natural Science Multimodal decoding of human liver regeneration. Nature.
Foundation of China (62127811, U23A20453, U21A20396, 2024;630(8015):158-165.
T2222029), the National Key Research and Development doi: 10.1038/s41586-024-07376-2
Program of China (2022YFA1104701), Initiative Scientific 6. Sun T, Pikiolek M, Orsini V, et al. AXIN2⁺
Research Program of Institute of Zoology (2023IOZ0101), Pericentral hepatocytes have limited contributions to liver
and the CAS Engineering Laboratory for Intelligent Organ homeostasis and regeneration. Cell Stem Cell. 2020;26(1):97-
Manufacturing (KFJ-PTXM-039). 107.e6.
doi: 10.1016/j.stem.2019.10.011
Conflict of interest 7. Raasch M, Fritsche E, Kurtz A, Bauer M, Mosig AS.
Microphysiological systems meet hiPSC technology -
The authors declare no conflicts of interest. new tools for disease modeling of liver infections in basic
research and drug development. Adv Drug Deliv Rev. 2019;
Author contributions 140:51-67.
Conceptualization: Yifan Hou, Xin Liu, Shen Ji, doi: 10.1016/j.addr.2018.06.008
Xinhuan Wang 8. Heymann F, Tacke F. Immunology in the liver — from
Investigation: Yifan Hou homeostasis to disease. Nat Rev Gastroenterol Hepatol.
Supervision: Qi Gu 2016;13(2):88-110.
Visualization: Yifan Hou doi: 10.1038/nrgastro.2015.200
Writing – original draft: Yifan Hou, Xin Liu 9. Palakkan AA, Hay DC, PR Anil Kumar, TV Kumary, Ross
Writing – review & editing: Yifan Hou, Xin Liu, Shen Ji, JA. Liver tissue engineering and cell sources: issues and
Xinhuan Wang, Qi Gu challenges. Liver Int. 2013;33(5):666-676.
doi: 10.1111/liv.12134
Ethics approval and consent to participate 10. Prior N, Inacio P, Huch M. Liver organoids: from basic
research to therapeutic applications. Gut. 2019;68(12):
Not applicable.
2228-2237.
doi: 10.1136/gutjnl-2019-319256
Consent for publication
11. Osonoi S, Takebe T. Organoid-guided precision hepatology
Not applicable. for metabolic liver disease. J Hepatol. 2024;80(5):
805-821.
Availability of data doi: 10.1016/j.jhep.2024.01.002

Not applicable. 12. Panwar A, Das P, Tan LP. 3D hepatic organoid-based
advancements in LIVER tissue engineering. Bioengineering
References (Basel). 2021;8(11):185.
doi: 10.3390/bioengineering8110185
1. Lemaigre FP. Mechanisms of liver development: concepts for 13. Yang Z, Liu X, Cribbin EM, Kim AM, Li JJ, Yong KT.
understanding liver disorders and design of novel therapies. Liver-on-a-chip: considerations, advances, and beyond.
Gastroenterology. 2009;137(1):62-79. Biomicrofluidics. 2022;16(6):061502.
doi: 10.1053/j.gastro.2009.03.035 doi: 10.1063/5.0106855
2. Ober EA, Lemaigre FP. Development of the liver: 14. Dalsbecker P, Beck Adiels C, Goksör M. Liver-on-a-chip
Insights into organ and tissue morphogenesis. J Hepatol. devices: the pros and cons of complexity. Am J Physiol
2018;68(5):1049-1062. Gastrointest Liver Physiol. 2022;323(3):G188-G204.
doi: 10.1016/j.jhep.2018.01.005 doi: 10.1152/ajpgi.00346.2021
3. Wang X, Yang L, Wang Y-C, et al. Comparative analysis of 15. Mirdamadi ES, Kalhori D, Zakeri N, Azarpira N, Solati-
cell lineage differentiation during hepatogenesis in humans Hashjin M. Liver tissue engineering as an emerging
and mice at the single-cell transcriptome level. Cell Res. alternative for liver disease treatment. Tissue Eng Part B Rev.
2020;30(12):1109-1126. 2020;26(2):145-163.
doi: 10.1038/s41422-020-0378-6 doi: 10.1089/ten.TEB.2019.0233

Volume 10 Issue 5 (2024) 143 doi: 10.36922/ijb.3819